Head-To-Head Survey: Elanco Animal Health (NYSE:ELAN) vs. Daxor (NASDAQ:DXR)

Elanco Animal Health (NYSE:ELAN) and Daxor (NASDAQ:DXR) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability and earnings.

Earnings and Valuation

This table compares Elanco Animal Health and Daxor”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elanco Animal Health	$4.44 billion	2.53	$338.00 million	$0.06	376.75
Daxor	N/A	N/A	N/A	N/A	N/A

Elanco Animal Health has higher revenue and earnings than Daxor.

Profitability

This table compares Elanco Animal Health and Daxor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Elanco Animal Health	0.78%	7.41%	3.64%
Daxor	N/A	N/A	N/A

Institutional & Insider Ownership

97.5% of Elanco Animal Health shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 0.9% of Elanco Animal Health shares are owned by insiders. Comparatively, 59.5% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of recent ratings and price targets for Elanco Animal Health and Daxor, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elanco Animal Health	1	3	7	2	2.77
Daxor	0	1	1	0	2.50

Elanco Animal Health presently has a consensus target price of $23.78, suggesting a potential upside of 5.19%. Daxor has a consensus target price of $25.00, suggesting a potential upside of 79.73%. Given Daxor’s higher possible upside, analysts plainly believe Daxor is more favorable than Elanco Animal Health.

Summary

Elanco Animal Health beats Daxor on 8 of the 10 factors compared between the two stocks.

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.